期刊文献+

部分脾动脉栓塞治疗特发性血小板减少性紫癜33例分析 被引量:1

部分脾动脉栓塞治疗特发性血小板减少性紫癜33例分析
下载PDF
导出
摘要 目的:探讨脾栓塞治疗特发性血小板减少性紫癜(ITP)的效果。方法:将33例特发性血小板减少性紫癜的患者随机分为对照组和观察组,两组患者均行脾动脉栓塞术治疗ITP,对照组栓塞面积约55%±10%,观察组患者栓塞面积约75%±10%。结果:观察组患者治疗效果明显高于对照组(P<0.05),具有统计学意义;治疗前后免疫球蛋白水平变化不明显(P>0.05),不具有统计学意义。结论:65%-85%脾栓塞效果明显,更持久,值得临床推广。 Objective: To analyze the effect of partial splenic embolization for idiopathic thrombocytopenic purpura (ITP). Methods: 33 ITP patients were randomized into 2 groups to receive splenic embolization with gelatin sponge paticles, and the embolized volume ranged between 65% and 85% in observation group, and between 45% and 65% in the control group. Result: The observation group has better clinical effect than the control group 1 year after the operation ( P 〈 0. 05 ) ; the splenic function in neither group underwent any significant changes after operation (P 〉 0. 05 ). Conclusion: 65% -85% of splenic embolization volumes will lead better clinical effect.
出处 《中国民族民间医药》 2011年第20期45-46,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 脾栓塞 血小板减少性紫癜 治疗 splenic embolization purpura cure
  • 相关文献

参考文献3

二级参考文献5

共引文献47

同被引文献27

  • 1秦平,陈峰,张春青,彭军,陈学良,侯明.大剂量地塞米松治疗慢性特发性血小板减少性紫癜的疗效观察[J].中华内科杂志,2005,44(6):451-452. 被引量:46
  • 2Drew Provan, Roberto Stasi, Adrian C, et al. International consensusreport on the investigation and management of primary immune thrombocytopenia[J]. Blood, 2010, 115: 168-186.
  • 3Xin-guang Liu, Ming Hou. Immune thrombocytopenia and B-cell-aActivating factor/a proliferation-inducing ligand [J]. Seminars in Hematology,2013,50:89-99.
  • 4Nishimoto T, Kuwana M, CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia [J].Seminars in Hematology,2013,50: 43 -49.
  • 5Xin Y, Zhang L, Chen Y, et al. The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia [J]. Plos One, 2015,10:1371.
  • 6Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylorieradication on platelet count in children with chronic idiopathic thrombocytopenic purpura [J].Hematology,2009,14(5): 282-285.
  • 7Takahashi T,Yujiri T,Shinohara K,et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of Hpyloriassociated chronic idiopathic thrombocytopenic purpura [J]. British Journal of Haematology, 2004,124:91-96.
  • 8Qiu JH, Shao 1, Zhou H, et al. Platelet desialylation is closely associated with cytotoxic T lymphocyte-mediated plateletdestruction in immune thrombocytopenia [J]. Blood, 2014, 124 (21): 463-463.
  • 9Wr6bel G,Dobaczewski G,Patkowski D,et al.Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia[J]. Pediatric Blood&Cancer,2006,47 (5) :729-730.
  • 10Neunert C, Lim W, Crowther M, et al. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood,2011,117(16):4190-4207.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部